Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-2001 | 10-2000 | |
| Sales | 2,402,800 | 3,287,900 |
| Cost of Goods | 1,677,800 | 1,679,000 |
| Gross Profit | 725,000 | 1,608,900 |
| Operating Expenses | 1,757,100 | 520,400 |
| Operating Income | -1,031,300 | 1,088,500 |
| Other Income | -889,400 | 371,900 |
| Pre-tax Income | -1,920,700 | 1,460,400 |
| Income Tax | -633,000 | 592,300 |
| Net Income Continuous | -1,287,700 | 868,100 |
| Net Income | $-1,287,700 | $868,100 |
| EPS Basic Total Ops | -11.48 | 8.40 |
| EPS Basic Continuous Ops | -11.45 | 8.42 |
| EPS Diluted Total Ops | -11.48 | 7.91 |
| EPS Diluted Continuous Ops | -11.45 | 7.89 |
| EBITDA(a) | $-833,500 | $1,234,700 |